Bureau Veritas to replace Vivendi on CAC40 index, Euronext says
Dec 17 (Reuters) - Vivendi VIV.PA is to be excluded
from the CAC40 share index from Dec. 23, Euronext ENX.PA said
on Thursday.
The Paris stock exchange operator said that Vivendi will be
replaced by Bureau Veritas BVI.PA as part of its quarterly
review.
It added that Casino CASP.PA , Euroapi EAPI.PA and
Eutelsat ETL.PA will be exluded from the SBF 120 share index
from Dec. 23. They will be replaced by Medincell MEDCL.PA ,
Planisware PLNW.PA and Robertet ROBF.PA .
(Reporting by Anna Peverieri
Editing by David Goodman
)
((Anna.Peverieri@thomsonreuters.com;))
Recent news on Medincell SA
See all newsBrief: Medincell Has Secured An Additional EUR 13.8 Million In Non-Dilutive Financing From Leading European Commercial Banks And Bpifrance
Teva gains after FDA approves monthly schizophrenia injection
Corrected: UPDATE 1-Teva wins FDA approval for monthly schizophrenia injection Weltruza
Teva wins FDA approval for monthly schizophrenia injection Weltruza
Brief: Medincell Announces Temporary Shares Trading Suspension On Euronext Paris